Background: Dystrophin has a key role in striated muscles mechanotransduction of
Dystrophin is a main cytoskeletal structure protein 21-28 involved in skeletal and cardiac muscle cells mechanotransduction 21,28-30 . Although dystrophin is present in vascular smooth muscle cells 25, 31-33 no functional study in blood vessels has been performed and especially in response to mechanical stimuli such as pressure and flow, the main effectors of vascular tone and blood supply 1-8 . The possibility that a specific vascular malfunction, such as a decrease in local blood flow supply to end-organs, has never been investigated in dystrophin-related diseases such as the Duchenne's dystrophy, although it might, at least, accelerate damages to tissues and especially damages to cardiac and skeletal muscles.
Thus, we tested the hypothesis that vascular mechanotransdution of the 2 main physical forces to which vessels are continuously submitted (pressure and flow) could involve dystrophin and that its absence might induce vascular disorders. Indeed, dystrophin has a key position between membrane structure proteins and the actin cytoskeleton, although never described as precisely in vascular cells, and disruption of the actin filaments has been shown to specifically affect vascular responses to flow 12 . We used carotid and mesenteric resistance arteries which represent the 2 main types of arteries, i.e., large conductance (or compliance) arteries using their elastic properties to damp the energy produced by the ejection of blood by the heart at each systole and resistance arteries using their muscular tone and endothelial relaxing capacity to regulate blood flow supply to organs.
METHODS

Isolated arteries
Mdx mice and their control (C57-Bl10) were obtained from Iffa-Credo (L'Arbresle, France). They were anesthetized for blood pressure measurement through a catheter in the left carotid artery 20 . Then, right carotid and mesenteric arteries were isolated and cannulated at both ends in a video monitored perfusion system 44 (LSI, Burlington, VT) as previously described 20,34,45,46 . Briefly, arteries were bathed in a physiological salt solution (pH 7.4, pO 2 160 mmHg, pCO 2 37 mmHg). Pressure was controlled by a servoperfusion system and flow generated by a peristaltic pump. Diameter changes were measured when intraluminal pressure was increased from 10 to 125 mmHg. Pressure we then set at 75 mmHg and flow increased by steps. At the end of each experiment arteries were perfused and superfused with a Ca 2+ -free physiological salt solution containing EGTA (2 mM) and sodium nitroprusside (10 µM) and pressure steps were repeated in order to determine the arteries passive diameter 20,34,45,46 . Contractions to phenylephrine (1nM to 10µM), KCl (80 mM) and calcium (0.1 to 1 mM in a calcium-free medium + 80 mM KCl) were separately tested. Dilation to acetylcholine and sodium nitroprusside were tested after preconstriction of the arteries with phenylephrine (50% of the maximal contraction) 20,34 .
Histomorphometrical analysis
Histomorphometry of the arteries was performed as previously described on segments of arteries previously mounted in the arteriograph as described above. Pressure was set at 75 mmHg and vessels were fixed in 10% formaldehyde in saline solution (30 min) and sectioned (10µm thick sections). Morphometric analysis was performed with an automated image processor 45-47 .
Immunolocalization of dystrophin and in situ confocal microscopy.
Segments of arteries mounted in embedding medium (Miles, Inc., Elkhart, USA), frozen in isopentane 45,46 . Immunostaining was then performed on transverse cross section (5 µm thin) incubated overnight at 4°C with anti-dystrophin antibodies (anti dys2, 1:20, Novacastra) and then incubated for 30 min at 37°C with anti-rabbit antibodies conjugated to peroxydase (Amersham). Samples were mesenteric resistance or carotid arteries, gracilis muscle and heart from mdx and control mice, as well as human internal mammary and mesenteric arteries. Positive staining was visualized as a brown-orange staining, using video microscopy 45,46 . In another group of experiments immunostaining of dystrophin was performed in isolated mesenteric arteries from control and mdx mice mounted in an arteriograph under a pressure of 75 mm Hg and a flow of 50 µl/min, so that vascular cells were left in physiological conditions. Cell membranes were permeabilized with β-escin (90 mg/ml, 10 min) to allow antibodies to reach dystrophin. A secondary antibody (anti IgG), bound to streptavidine and Texas-red was used to labeled anti-dystrophin antibodies 45,46 .
Fluorescence staining was visualized using an Axiophot inverted microscope (Nikon, Tokyo, Japan) equipped with an Odyssey XL confocal scanning system (Noran Instruments, Midleton, WI, USA) allowing to visualized staining of endothelial cells in the luminal side of the perfused artery.
Finally, we also used human mammary and epiploic arteries to immunolocalized, as described above, dystrophin in endothelial and smooth muscle cells. These human arteries were isolared from excess material normally discared after surgery.
Statistical analysis
Results were expressed as means ± standard error (s.e.mean). EC 50 or IC 50 (concentration of agonist required to induce half the maximum response) and E max (maximal response) were calculated for each artery 20 . Significance of the differences between groups was determined by analysis of variance (one or two factor ANOVA, or ANOVA for consecutive measurements, when appropriate). Means were compared by paired t test or by Bonferroni's test for multigroup comparisons. P values less than 0.05 were considered to be significant.
Results
Animals
Body weight was not affected by the absence of dystrophin (33±3 vs 35±3g, mdx vs control mice, n=12 per group). Similarly, blood pressure was normal in mdx mice (mean arterial pressure: 86±5 mmHg in mdx vs 88±6 mmHg in controls mice, n=12 per group).
Isolated arteries
In isolated carotid and mesenteric resistance arteries under a physiological level of intraluminal pressure a basal (myogenic) tone develops, which was antagonized by flow 6 (shear stress)-induced dilation. Thus, increasing flow by steps induced a progressive dilation (figure 1). In both carotid and mesenteric resistance arteries flow (shear stress)-induced dilation was strongly attenuated in mdx mice ( fig. 1 ). Pressure (tensile stress)-induced tone (myogenic in resistance arteries) was unaffected by the absence of dystrophin (mdx mice) in both type of vessels (figure 2). Other endothelium dependent (acetylcholine) or independent (sodium nitroprusside) forms of dilation were not modified in mdx mice, in both carotid and resistance arteries (table 1) . Similarly, contractions to calcium, KCl or phenylephrine (table 1), in addition to basal tone due to pressure (figure 2)
were not affected by the lack of dystrophin.
Blockade of NO synthesis by L-NAME reduced flow-induced dilation in both types of arteries ( figure 3, top) . L-NAME was less efficient in arteries from mdx mice stimulated by flow than in control mice (figure 3, bottom graphs). Direct stimulation of cGMPdependent dilation (endothelium-independent) with sodium nitroprusside was unaffected in mdx mice (table 1) .
Angiotensin II or endothelin-1 receptors inhibition, did not affect flow-induced dilation in arteries from mdx mice (n=6 per group, data not shown).
Histomorphometry and passive properties of the vascular wall
Although no significant change in arterial wall thickness (figure 4) or passive diameter (figure 5, mesenteric arteries and figure 6, carotid arteries) was found, arterial wall structure was affected by the absence of dystrophin, as visualized by a larger wall to lumen ratio (figure 4) and a lower compliance and distensibility of the carotid artery (figure 6).
Immunolocalization of dystrophin
The protein dystrophin was present in both vascular smooth muscle and endothelial cells in control mice (absent in mdx mice), but also in human internal mammary and mesenteric resistance arteries (figure 7). Confocal scanning of an isolated arteries, mounted in an arteriograph in order to maintain physiological levels of pressure and flow in the lumen of the arteries, shows that dystrophin is present in both endothelial and smooth muscle cells. In these cells, dystrophin was located at the level of the plasma membrane ( figure 8 ). This and our previous observations in mice lacking the gene encoding for vimentin 20 and in rats rendered hypertensive with a chronic infusion of endothelin 34 strengthens the hypothesis that flow-dilation has a key role in the control of local blood flow but is not necessarily and/or directly related to the basal level of systemic blood pressure.
Flow-dilation was specifically attenuated in mdx mice. Other endothelium-dependent (acetylcholine) and independent (sodium nitroprusside) dilation were not modified in mdx mice. Similarly, contraction to calcium, KCl or phenylephrine, in addition to myogenic tone due to pressure were not affected by the lack of dystrophin, showing that no endothelium dysfunction and no defect in smooth muscle contractility or vasorelaxant properties could be involved in the reduction in dilation to shear stress found in arteries from mdx mice.
Although no significant change in arterial wall thickness or passive diameter was found, arterial wall structure was affected by the absence of dystrophin, as visualized by a larger wall to lumen ratio and a lesser compliance and distensibility (figure 2). Nevertheless, these changes cannot explain a change only in endothelial response to flow, without affecting other forms of tone. Indeed, in both mdx and control mice arterial tone before inducing flow-dilation was similar.
Nitric oxide (NO) is major relaxing agent released by the endothelium after flow stimulation 5,7,35-38 and the blockade of its synthesis was less efficient in arteries from mdx mice stimulated by flow, whereas direct stimulation of cGMP-dependent dilation 8 with sodium nitroprusside was unaffected in mdx mice. Thus arteries from mdx mice are less able to produce NO in response to shear stress. In addition, arteries from mdx mice did not produce more endothelium-derived vasoconstrictor agents when stimulated by flow, as angiotensin II or endothelin-1 receptors inhibition did not affect flow-induced dilation in arteries from mdx mice. Thus the lack of dystrophin caused a specific defect in the transduction of shear stress into a dilation through the NO-cGMP pathway in endothelial cells being able to normally dilate to other relaxing stimuli. This attenuation in flow-induced dilation might lead to a lesser adaptation to increases in blood flow in organs when a metabolic need requires a higher blood flow supply. In addition, flow (shear stress at the surface of the endothelial cells) being a major stimulus for vascular cells growth and angiogenesis 8,38-40 , a defect in flow-mechanotransduction due to the absence of dystrophin could be deleterious for the angiogenic process and consequently blood flow supply to organs might be affected when an increase in blood flow is required in situations such as exercise. In support of this statement, skeletal muscle contraction induces a NOS-I-dependent arteriolar dilation which is decreased in mdx mice. This lower dilation has been attributed to a lower capacity of the skeletal muscle to produce NO 41 but in view of the present study we can also postulate that the increase in blood flow required for the contraction might not be high enough in mdx mice, leading to a lesser NO production in blood vessels as well. Also in support of our hypothesis the occurrence of ischemia has been shown in skeletal and cardiac muscles of dystrophin deficient patients 42,43 .
Finally, the protein dystrophin was present in both vascular smooth muscle and endothelial cells in control mice (absent in mdx mice) and also in human internal mammary and mesenteric resistance arteries. This location is in agreement with the studies performed in skeletal and cardiac muscle cells 29 and strengthens the possibility that dystrophin, in vascular endothelial cells plays a major role in mechanotransduction.
Flow-mechanotransduction also involves integrins 48 . Although it is tempting to link the two proteins in the same pathway, such a possibility requires further investigations. In addition, integrins blockade with RGD peptides may suppress totally flow-induced dilation 48 , whereas the absence of dystrophin in mdx mice decreased the response to 40-50 % of that in control mice. This could reflect an adaptation of the endothelial cells to the chronic absence of dystrophin and other proteins such as dystrophin-related proteins could be involved in flow-mechanotransduction in mdx mice. Finally, the transduction pathway beyond dystrophin leading to the activation of NO synthesis, and especially the type of kinases involved, also remains to be elucidated 9
In conclusion we found that dystrophin plays a key role in the Confocal scanning was performed at a high speed (30 images per second) due to the movements of the vessel wall during perfusion under pressure.
